Publications

Van Der Gucht, A., Aoun Sebaiti, M., Itti, E., Aouizerate, J., Evangelista, E., Chalaye, J., Gherardi, R., Ragunathan-Thangarajah, N., Bachoud-Levi, A. & Authier, F. (2015). Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis. PloS one, 10(6), e0128353. doi:10.1371/journal.pone.0128353

Vandendriessche, C., Bastian, M., Peyre, H., Stordeur, C., Asquaviva, E., Bahadori, S., Delorme, R. & Sackur, J. (2017). Attentional Lapses in Attention-Deficit/Hyperactivity Disorder: Blank Rather Than Wandering Thoughts. Psychological Science, 28(10), 1375-1386. doi:10.1177/0956797617708234

Varani, K., Bachoud-Levi, A., Mariotti, C., Tarditi, A., Abbracchio, M., Gasperi, V., Borea, P., Dolbeau, G., Gellera, C., Solari, A., Rosser, A., Naji, J., Handley, O., Maccarrone, M., Peschanski, M., Didonato, S. & Cattaneo, E. (2007). Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiology of Disease, 27(1), 36-43. doi:10.1016/j.nbd.2007.03.011

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & CYST-HD Study Group, . (2017). A randomized, Double-Blind, placebo-controlled trial evaluating cystéamine in Huntington’s disease. Mov. Disord., 32(6), 932-936

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & Cyst-Hd Study, G. (2017). A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 32(6), 932-936. doi:10.1002/mds.27010

Villafane, G., Thiriez, C., Audureau, E., Straczek , C., Kerschen, P., Cormier-Dequaire , F., Van Der Gucht, A., Gurruchaga, J., Evangelista, E., Defer, G., Damier, P., Remy, P., Itti, E., Fenelon, G. & Quéré-Carne M, M. (2017). High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol , 25, 120-127. doi:10.1111/ene.13474

Visser, E., Keuken, M., Douaud, G., Gaura, V., Bachoud-Levi, A., Remy, P., Forstmann, B. & Jenkinson, M. (2016). Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation Tool. NeuroImage, 125, 479-497. doi:10.1016/j.neuroimage.2015.10.013

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E., Bachoud-Levi, A. & Registry Investigators Of The European Huntington’s Disease, N. (2013). β-defensin genomic copy number does not influence the age of onset in huntington’s disease. Journal of Huntington's Disease, 2(1), 107-124. doi:10.3233/JHD-130047

Whone, A., Bailey, D., Remy, P., Pavese, N. & Brooks, D. (2004). A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45(7), 1135-45.

Whone, A., Watts, R., Stoessl, A., Davis, M., Reske, S., Nahmias, C., Lang, A., Rascol, O., Ribeiro, M., Remy, P., Poewe, W., Hauser, R., Brooks, D. & Real-Pet Study, G. (2003). Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Annals of neurology, 54(1), 93-101. doi:10.1002/ana.10609

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2018). Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714. J Nucl Med, 59(2), 307-314. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Kuhnast, B., Leroy, C., Remy, P., Stankoff, B. & Bottlaender, M. (2018). Impact of endothelial TSPO on the quantification of 18F-DPA714 in the normal human brain. , 59(2), 307-314. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2017). Impact of endothelial TSPO on the quantification of 18F-DPA-714. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. doi:10.2967/jnumed.117.195396

Witjes-Ané, M., Mertens, B., Van Vugt, J., Bachoud-Levi, A., Van Ommen, G. & Roos, R. (2007). Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. The Journal of neuropsychiatry and clinical neurosciences, 19(3), 310-7. doi:10.1176/jnp.2007.19.3.310

Woodgate, S. , Morgan-Jones, P. , Clinch, S. , Drew, C. , Playle, R. , Bennasar, M. , Hicks, Y. , Holt, C. , Bachoud-Levi, A., Massart, R., Craufurd, D., Kirby, N. , Hamana, K. , Schubert, R. , Reilmann, R., Rosser, A. & Busse, M. (2021). Objectively characterizing Huntington’s disease using a novel upper limb dexterity test. Journal of Neurology, 268, 2550-2559. doi:10.1007/s00415-020-10375-8

Youssov, K., Dolbeau, G., Maison, P., Boissé, M., Cleret de Langavant, L., Roos, R. & Bachoud-Levi, A. (2013). The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study. Movement disorders : official journal of the Movement Disorder Society, 28(14), 1995-2001. doi:10.1002/mds.25678

Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E., Sassone, J., Ciammola, A., Bachoud-Levi, A., Tabrizi, S., Di Donato, S. & Cattaneo, E. (2011). Brain-derived neurotrophic factor in patients with Huntington's disease. PloS one, 6(8), e22966. doi:10.1371/journal.pone.0022966